Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading ->
Many Geneva-based health agencies have worked together for years to improve global access to diagnostics and treatment, but the COVID-19 pandemic has necessitated much closer collaboration and speedier decision-making. This is according to experts from the WHO co-sponsored  “ACT Accelerator” medicine access partnership – including UNITAID, the Foundation for Innovative New Diagnostics (FIND), and the […] Continue reading ->
Third in a series –  Even before the coronavirus struck, large swathes of Africa, as well as parts of South-East Asia and Latin America, still relied on fragmented paper-based medical records, making it difficult to track people’s medical history – and thus provide high-quality treatment and care. The Virtual Innovation Fair, which is a key […] Continue reading ->
Second in a series – On Wednesday, 18 November, at 2pm CET, leading experts at the Geneva Health Forum (GHF) 2020 will provide their take on how to move forward on the recently approved WHO global strategy to accelerate the elimination of cervical cancer, which kills 300,000 women every year, mostly in low-resource settings like […] Continue reading ->
Spain announced a state of emergency on Sunday and ordered a nationwide curfew just days after becoming the first Western European country to surpass one million confirmed cases. The curfew and restrictions on gatherings of more than six people has made Spain the latest country in Europe to toughen its guidelines, after France placed 46 […] Continue reading ->
The COVID-19 pandemic will end at some point. But TB, tobacco use, air pollution and other lung diseases will continue to “steal the breath and life of millions of people every year”, unless we reimagine the future, said WHO’s director-general Dr Tedros Adhanon Ghebreyesus, appearing at the opening of the 51st Union World Conference On […] Continue reading ->
Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading ->
  A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week.  The closed door discussion lays the groundwork for what could prove to  be the most significant public debate over […] Continue reading ->